Cervavac is India’s first indigenously developed quadrivalent HPV vaccine manufactured by the Serum Institute of India. It provides protection against four major Human Papillomavirus (HPV) types: 6, 11, 16, and 18. HPV types 16 and 18 are responsible for nearly 70% of cervical cancer cases, while types 6 and 11 cause around 90% of genital warts. Cervavac works by stimulating the immune system to produce antibodies that help protect against HPV infections and related cancers. The vaccine is suitable for both girls and women within the recommended age groups as part of cervical cancer prevention programs. Each pack contains a 0.5 mL single-dose vial intended for intramuscular injection. The vaccine must be administered by a qualified healthcare professional under medical supervision. Cervavac offers an affordable and accessible solution to HPV prevention, aiming to reduce cervical cancer burden in India.
Specifications
- Service at Doorstep : FREE Home vaccination availability
- Cold Chain Compliance : Maintains 2-8°C
- VACCINATION KIT : AVAILABLE
- VACCINATION OFFICER : YES